Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

MCRBMCRB

Showing 4 of 27 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in SERES THERAPEUTICS INC

As of its Q1 2025 13F, Charles Schwab Investment Management held 834,107 shares of MCRB (Seres Therapeutics), worth $583,958. Charles Schwab Investment Management's 13F filings listed MCRB from Q4 2018 to Q1 2025, 26 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$708,362

Total Shares Change

-748,718

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$9.10
0
2025-Q1
Decreased
834,107
-3.7%
$583,9580.0%$14.42
0
2024-Q4
Increased
865,825
+15.6%
$719,5010.0%$16.62
28
2024-Q3
Increased
748,718
+42.4%
$708,3620.0%$18.38
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used